LENSAR (LNSR) to Release Earnings on Thursday

Key Points

• LENSAR is anticipated to release its Q2 2025 earnings on August 14th, with projected losses of ($0.08) per share and revenues estimated at $16.55 million.
• In its last earnings report on May 8th, LENSAR reported a significant miss with ($2.32) EPS and revenues of only $11.53 million, compared to analyst expectations.
• Acadian Asset Management LLC recently acquired a new stake in LENSAR, purchasing 18,243 shares valued at approximately $257,000, contributing to institutional investors owning 40.15% of the stock.

LENSAR (NASDAQ:LNSR - Get Free Report) will likely be issuing its Q2 2025 quarterly earnings data before the market opens on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $16.55 million for the quarter.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07). The company had revenue of $11.36 million during the quarter, compared to analysts' expectations of $16.55 million. LENSAR had a negative return on equity of 2,710.00% and a negative net margin of 84.49%.

LENSAR Stock Performance

Shares of LNSR traded up $0.03 during trading hours on Friday, hitting $12.87. The company had a trading volume of 71,426 shares, compared to its average volume of 61,924. The firm has a fifty day moving average price of $12.92 and a 200-day moving average price of $13.01. The stock has a market capitalization of $151.74 million, a price-to-earnings ratio of -3.06 and a beta of 0.50. LENSAR has a 52-week low of $3.64 and a 52-week high of $17.31.

Institutional Investors Weigh In On LENSAR

Several large investors have recently bought and sold shares of LNSR. Goldman Sachs Group Inc. bought a new stake in LENSAR in the 1st quarter worth about $546,000. Acadian Asset Management LLC bought a new stake in LENSAR in the 1st quarter worth about $257,000. Finally, Geode Capital Management LLC increased its holdings in LENSAR by 103.9% in the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company's stock worth $2,890,000 after buying an additional 111,802 shares in the last quarter. 40.15% of the stock is currently owned by institutional investors.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.